Optimal Medical Therapy for Heart Failure and Integrated Care in Patients With Atrial Fibrillation: A Report From the ESC-EHRA EORP Atrial Fibrillation Long-Term General Registry.

Background: Heart failure (HF) often occurs in patients with atrial fibrillation (AF), with a major impact on prognosis. Few data are available on the effect of integrated treatment strategies to improve prognosis in patients with AF. We aimed to evaluate the association between HF (according to left ventricular ejection fraction [LVEF]), HF optimal medical therapy and adherence to the Atrial Fibrillation Better Care pathway, and major outcomes in patients with AF.

The Valorisation of Biochar Produced from Black Liquor Pyrolysis for the Development of CO Adsorbents.

The paper manufacturing process produces liquid and gaseous alternative fuels, as well as solid wastes. These can be subsequently treated through chemical processing, oxidation, and thermal activation, resulting in adsorbent materials with CO adsorption capacities. The valorisation of black liquor waste resulting from paper manufacturing was achieved through a catalytic pyrolysis process using two catalysts previously prepared in house (Cu-Zn-MCM-41 and Ni-SBA-16).

Routine invasive strategy and frailty burden in non-ST-segment elevation acute myocardial infarction.

Objective: To assess the prognostic impact of a routine invasive strategy according to the frailty burden in patients with non-ST-segment elevation myocardial infarction (NSTEMI) from the MOSCA-FRAIL clinical trial.

Methods: The MOSCA-FRAIL trial randomized 167 frail patients, defined by a Clinical Frailty Scale (CFS) ≥ 4, with NSTEMI to an invasive or conservative strategy. The primary endpoint was the number of days alive and out of hospital (DAOH) one year after discharge.